3,3A,6,6A-Tetrahydrofuro[3,4-b]furan derivatives and anti-ulcer

Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2603436, 260485R, 260592, C07D49304

Patent

active

040326519

ABSTRACT:
Pharmaceutical compositions containing 3,3a,6,6a-tetrahydrofuro[3,4-b]furan derivatives including canadensolide and 3-epi-dihydrocanadensolide. Novel 3,3a,6,6a-tetrahydrofuro[3,4-b]furan derivatives bearing a variety of substituents in the 3- and 6-positions selected from alkyl, phenyl, alkoxycarbonyl, methylene, benzylthiomethyl and optionally substituted phenylthiomethyl. The compositions and novel compounds show anti-ulcer activity and are useful in the treatment of gastric or duodenal ulcers.

REFERENCES:
patent: 3930014 (1975-12-01), Aldridge et al.
Yoshikoshi, Japan Kokai 73-40, 796, Jan. 15, 1973 (cited as C.A. 79:66338d).
Zalinyan, et al., Arm. Khim. Zh. 1973, 26(12) 1015-1019 (cited as C.A. 81:3701n).
Mukaiyama, et al., Bull. Soc. Chem. Jap. 1971, 44(1), 161-166 (cited as C.A. 74:76349u).
Yoshikoshi (II), Japan Kokai 73-40, 797, Jan. 15, 1973 (cited as C.A. 79:66337d).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3,3A,6,6A-Tetrahydrofuro[3,4-b]furan derivatives and anti-ulcer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,3A,6,6A-Tetrahydrofuro[3,4-b]furan derivatives and anti-ulcer , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,3A,6,6A-Tetrahydrofuro[3,4-b]furan derivatives and anti-ulcer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1521983

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.